Related Experiment Video
Updated: Jul 5, 2026

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
Novel 3-carboxamide-coumarins as potent and selective FXIIa inhibitors
Séverine Robert1, Carine Bertolla, Bernard Masereel
1Department of Pharmacy, Drug Design and Discovery Center, FUNDP, University of Namur, Namur, Belgium.
Abstract:
Recently, FXIIa was highlighted as an original attractive target for the development of new anticoagulant drugs with low rates of therapy-related hemorrhages. In this work, we describe the development of a new series of 3-carboxamide-coumarins that are the first potent and selective nonpeptidic inhibitors of FXIIa.
More Related Videos
10:24A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
10:01Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
Inhibitors of Bacterial DNA Synthesis
Antifungal Agents
Inhibitors of Viral Protein Synthesis
Anthelminthic Agents
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists